Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuang Yan

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Aging|November 21, 2023
Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patientsJin-Rong He, Dan Li, Qun-Xian Zhang, et al.
Scientific Reports|May 23, 2024
Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUADJiu-Ling Chen, Chuang-Yan Wu, Xiang-Yu Luo, et al.
Colloids and Surfaces. B, Biointerfaces|April 11, 2026
Composition-tunable hyaluronic acid/zwitterionic hybrid fibrous biointerfaces for programmable CD44-mediated cell adhesion and flow-triggered releaseI-Tsu Chyuan, Ming-Huang Chiu, Chuang-Yan Lai, et al.
Experimental and Therapeutic Medicine|June 14, 2014
Antagonistic effect of protein extracts from <i>Streptococcus sanguinis</i> on pathogenic bacteria and fungi of the oral cavityShengli Ma, Hui Li, Chuang Yan, et al.
Frontiers in Immunology|December 22, 2022
Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinomaQiang Guo, Chuang-Yan Wu, Ni Jiang, et al.
Frontiers in Oncology|October 24, 2022
TRAT1 overexpression delays cancer progression and is associated with immune infiltration in lung adenocarcinomaXiao-Yue Xiao, Qiang Guo, Song Tong, et al.
BMC Cancer|March 27, 2023
The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinomaSong Tong, Ni Jiang, Jun-Hao Wan, et al.
Aging|January 20, 2024
<i>SLC7A8</i> overexpression inhibits the growth and metastasis of lung adenocarcinoma and is correlated with a dismal prognosisFang-Ming Wang, Li-Qiang Xu, Zhong-Chao Zhang, et al.
Frontiers in Genetics|March 14, 2022
Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung CancerQiang Guo, Xiao-Yue Xiao, Chuang-Yan Wu, et al.
Heliyon|July 2, 2024
Downregulation of DIP2B as a prognostic marker inhibited cancer proliferation and migration and was associated with immune infiltration in lung adenocarcinoma via CCND1 and MMP2Chuang-Yan Wu, Zhao Liu, Wei-Min Luo, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Aging|November 21, 2023
Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patientsJin-Rong He, Dan Li, Qun-Xian Zhang, et al.
Scientific Reports|May 23, 2024
Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUADJiu-Ling Chen, Chuang-Yan Wu, Xiang-Yu Luo, et al.
Colloids and Surfaces. B, Biointerfaces|April 11, 2026
Composition-tunable hyaluronic acid/zwitterionic hybrid fibrous biointerfaces for programmable CD44-mediated cell adhesion and flow-triggered releaseI-Tsu Chyuan, Ming-Huang Chiu, Chuang-Yan Lai, et al.
Experimental and Therapeutic Medicine|June 14, 2014
Antagonistic effect of protein extracts from <i>Streptococcus sanguinis</i> on pathogenic bacteria and fungi of the oral cavityShengli Ma, Hui Li, Chuang Yan, et al.
Frontiers in Immunology|December 22, 2022
Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinomaQiang Guo, Chuang-Yan Wu, Ni Jiang, et al.
Frontiers in Oncology|October 24, 2022
TRAT1 overexpression delays cancer progression and is associated with immune infiltration in lung adenocarcinomaXiao-Yue Xiao, Qiang Guo, Song Tong, et al.
BMC Cancer|March 27, 2023
The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinomaSong Tong, Ni Jiang, Jun-Hao Wan, et al.
Aging|January 20, 2024
<i>SLC7A8</i> overexpression inhibits the growth and metastasis of lung adenocarcinoma and is correlated with a dismal prognosisFang-Ming Wang, Li-Qiang Xu, Zhong-Chao Zhang, et al.
Frontiers in Genetics|March 14, 2022
Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung CancerQiang Guo, Xiao-Yue Xiao, Chuang-Yan Wu, et al.
Heliyon|July 2, 2024
Downregulation of DIP2B as a prognostic marker inhibited cancer proliferation and migration and was associated with immune infiltration in lung adenocarcinoma via CCND1 and MMP2Chuang-Yan Wu, Zhao Liu, Wei-Min Luo, et al.
Pageof 5